Dow Down0.92% Nasdaq Down0.83%

Imprimis Pharmaceuticals, Inc. (IMMY)

-NasdaqCM
8.00 Up 0.10(1.27%) Oct 22, 3:59PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 668   1   3   3  
Cost of Revenue477   -   -   -  
Gross Profit 191   1   3   3  
Operating Expenses
Research Development36  60  14  469  
Selling General and Administrative2,758  2,277  1,882  1,623  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (2,603) (2,335) (1,893) (2,090)
Income from Continuing Operations
Total Other Income/Expenses Net9  10  11  12  
Earnings Before Interest And Taxes(2,594)(2,325)(1,882)(2,077)
Interest Expense2   -   -   -  
Income Before Tax(2,596)(2,325)(1,882)(2,077)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(2,596)(2,325)(1,882)(2,077)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (2,596) (2,325) (1,882) (2,077)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (2,596) (2,325) (1,882) (2,077)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.